EIF2AK3 and neoplasm: Animal studies showed that expression of O-GlcNAcylation-mutant FBP1 reduced tumor growth with correspondingly enhanced cell apoptosis rates, and these effects were eliminated by mutations of PERK-phosphorylated S170 or protein phosphatase activity-required C129.